Clinical trials data
Selective Reminding Task in dementia and Alzheimer's trials: 76 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names the Selective Reminding Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 76
- Name it in a primary outcome, 45%
- 34 of 76
Tests named in the same studies
- 1
Trail Making Test28 studies, 8 as a primary outcome
- 2
Symbol Coding24 studies, 10 as a primary outcome
- 3
Category Fluency23 studies, 4 as a primary outcome
- 4
Short Story Recall21 studies, 10 as a primary outcome
- 5
Verbal Fluency20 studies, 6 as a primary outcome
- 6
Digit Span Test15 studies, 3 as a primary outcome
- 7
Stroop Color-Word Test14 studies, 8 as a primary outcome
- 8
Picture Naming Test12 studies, 3 as a primary outcome
- 9
Clock Drawing Task8 studies, 2 as a primary outcome
- 10
Matrix Reasoning6 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 3 | 2 |
| 2009 | 0 | 0 |
| 2010 | 5 | 2 |
| 2011 | 1 | 1 |
| 2012 | 4 | 2 |
| 2013 | 6 | 3 |
| 2014 | 3 | 1 |
| 2015 | 3 | 2 |
| 2016 | 1 | 0 |
| 2017 | 3 | 1 |
| 2018 | 3 | 2 |
| 2019 | 7 | 3 |
| 2020 | 1 | 0 |
| 2021 | 8 | 2 |
| 2022 | 7 | 3 |
| 2023 | 5 | 2 |
| 2024 | 7 | 3 |
| 2025 | 4 | 2 |
| 2026 | 3 | 1 |
Phases and study sizes
By phase
- Early phase 13 studies, 0 as a primary outcome
- Phase 13 studies, 1 as a primary outcome
- Phase 1/23 studies, 0 as a primary outcome
- Phase 213 studies, 5 as a primary outcome
- Phase 2/35 studies, 3 as a primary outcome
- Phase 35 studies, 1 as a primary outcome
- Phase 44 studies, 2 as a primary outcome
- Not applicable29 studies, 14 as a primary outcome
- Observational11 studies, 8 as a primary outcome
Participants per study
- Phase 263 median, 47 to 139
- Not applicable86 median, 50 to 150
- Observational250 median, 143 to 868
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 12 | 63 | 47 to 139 |
| Not applicable | 29 | 86 | 50 to 150 |
| Observational | 11 | 250 | 143 to 868 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day4 outcomes, 4 as a primary outcome
- Up to 4 weeks6 outcomes, 1 as a primary outcome
- 1 to 3 months11 outcomes, 4 as a primary outcome
- 3 to 6 months14 outcomes, 5 as a primary outcome
- 6 to 12 months16 outcomes, 8 as a primary outcome
- 1 to 2 years11 outcomes, 4 as a primary outcome
- Over 2 years12 outcomes, 6 as a primary outcome
- No duration given2 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
74 of the 76 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting16 studies, 6 as a primary outcome
- Not yet recruiting3 studies, 1 as a primary outcome
- Active, not recruiting1 studies, 0 as a primary outcome
- Completed41 studies, 20 as a primary outcome
- Stopped early6 studies, 3 as a primary outcome
- Status unknown9 studies, 4 as a primary outcome
What they test
- Behavioral14 studies, 7 as a primary outcome
- Drug33 studies, 11 as a primary outcome
- Device11 studies, 4 as a primary outcome
- Dietary supplement8 studies, 4 as a primary outcome
- Procedure5 studies, 3 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Biological2 studies, 1 as a primary outcome
- Radiation2 studies, 1 as a primary outcome
- Genetic1 studies, 0 as a primary outcome
- Other11 studies, 4 as a primary outcome
- None given5 studies, 5 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States37 studies, 14 as a primary outcome
- France16 studies, 5 as a primary outcome
- Italy14 studies, 5 as a primary outcome
- Spain8 studies, 5 as a primary outcome
- United Kingdom8 studies, 4 as a primary outcome
- Canada7 studies, 2 as a primary outcome
- Argentina5 studies, 1 as a primary outcome
- Australia5 studies, 2 as a primary outcome
- Germany5 studies, 1 as a primary outcome
- Chile4 studies, 0 as a primary outcome
- Mexico4 studies, 1 as a primary outcome
- Sweden4 studies, 2 as a primary outcome
39 countries in all. A study with sites in several counts in each; 3 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name the Selective Reminding Task: 27 of 41, 66%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name the Selective Reminding Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 10, 24% | 776, 10% |
| Results on ClinicalTrials.gov only | 8, 20% | 1,139, 14% |
| A results paper only | 9, 22% | 1,711, 22% |
| Neither | 14, 34% | 4,327, 54% |
The 76 studies
76 studies match. 34 name the Selective Reminding Task in a primary outcome. Median size 84 participants. Median time to the primary outcome: 10 months.
Loading 76 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 3 | 2 |
| 2009 | 0 | 0 |
| 2010 | 5 | 2 |
| 2011 | 1 | 1 |
| 2012 | 4 | 2 |
| 2013 | 6 | 3 |
| 2014 | 3 | 1 |
| 2015 | 3 | 2 |
| 2016 | 1 | 0 |
| 2017 | 3 | 1 |
| 2018 | 3 | 2 |
| 2019 | 7 | 3 |
| 2020 | 1 | 0 |
| 2021 | 8 | 2 |
| 2022 | 7 | 3 |
| 2023 | 5 | 2 |
| 2024 | 7 | 3 |
| 2025 | 4 | 2 |
| 2026 | 3 | 1 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 13, NIH 1, other 62. Interventional 65, observational 11.
As a primary outcomeSecondary or other outcomeThe Selective Reminding Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07856043 | Start2026 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Cardiovascular disease | Participants18 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07730671 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants121 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07717411 | Start2026 | PhasePhase 3 | ConditionsDementia and Alzheimer's | Participants1,600 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07664865 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants250 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07399418 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07233512 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants26 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07064226 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants102 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06953167 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06668610 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06662526 | Start2024 | PhasePhase 4 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Depression and bipolar disorder | Participants250 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06647498 | Start2024 | PhasePhase 2/3 | ConditionsDementia and Alzheimer's | Participants280 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06492967 | Start2021 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants1,065 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06416072 | Start2023 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants3,000 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06174038 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Hearing loss | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06112639 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Multiple sclerosis, Cancer | Participants192 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06094452 | Start2020 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants84 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06080659 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Parkinson's disease | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05984446 | Start2019 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants86 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05943925 | Start2021 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Parkinson's disease | Participants240 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05924425 | Start2024 | PhasePhase 4 | ConditionsDementia and Alzheimer's, Sleep and sleep disorders | Participants62 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05806697 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants240 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05699330 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants6 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05480358 | Start2019 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05468268 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05433493 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants142 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use the Selective Reminding Task?
76 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 34 of them in a primary outcome: 5% of the condition's 1,673 studies with a cognitive outcome, against 1% of all of them. It is the 10th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with the Selective Reminding Task?
The Trail Making Test (28 studies), Symbol Coding (24 studies) and Category Fluency (23 studies).
How many participants do phase 2 dementia and Alzheimer's trials that use the Selective Reminding Task enroll?
Half of the phase 2 studies that name it enroll 63 participants or fewer, and the middle half enroll 47 to 139. 12 of them give a size.
When do dementia and Alzheimer's trials measure the Selective Reminding Task?
Half of the primary outcomes that name the Selective Reminding Task are measured within 10 months of the start, and the middle half from 12 weeks to 2 years. 32 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use the Selective Reminding Task have reported results?
27 of the 41 completed studies that name it, 66%, have reported results: 18 posted them on ClinicalTrials.gov, 19 have a results paper linked to the registry record, and 10 did both. The other 14 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Selective Reminding Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.